Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.

Neuro-oncology - 5 Jul 2018

Peyre Matthieu, Gauchotte Guillaume, Giry Marine, Froehlich Sébastien, Pallud Johan, Graillon Thomas, Bielle Franck, Cazals-Hatem Dominique, Varlet Pascale, Figarella-Branger Dominique, Loiseau Hugues, Kalamarides Michel

Abstract excerpt

Background: Following recent studies underlining the differences between de novo and secondary anaplastic meningiomas and the prognostic value of telomerase reverse transcriptase (TERT) promoter mutation, we decided to conduct a multicenter retrospective study to address these questions and determine specific prognostic factors in each of these 2 anaplastic meningioma subgroups. Methods: Among the 68 meningioma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Meningeal Neoplasms

Share to Meningioma

Share to Neoplasm Recurrence, Local

Share to Survival Rate

Share to Telomerase

Source

Open in PubMed Open full text

Identifiers

PMID: 29216385
DOI: 10.1093/neuonc/nox231
PMCID: PMC6280137

Genes

TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.PMID 29216385Read ↗

Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical OutcomeSemantic proximity Read ↗

Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas.Semantic proximity Read ↗

Meningiomas: A review of general, histopathological, clinical and molecular characteristics.Semantic proximity Read ↗

ARID1A and TERT promoter mutations in dedifferentiated meningioma.Semantic proximity Read ↗

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.Semantic proximity Read ↗

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.Semantic proximity Read ↗

TERT promoter mutations in primary and secondary WHO grade III meningiomaSemantic proximity Read ↗

Progression-Free Survival and Molecular Features of Recurrent Intracranial Meningiomas: A Single-Center Retrospective StudySemantic proximity Read ↗

Human TERT Promoter Mutations in Atypical and Anaplastic MeningiomasSemantic proximity Read ↗

DE NOVO VERSUS TRANSFORMED ATYPICAL AND ANAPLASTIC MENINGIOMASSemantic proximity Read ↗

Multiomic and clinical analysis of multiply recurrent meningiomas reveals risk factors, underlying biology, and insights into evolutionSemantic proximity Read ↗

Molecular characteristics of meningiomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.